Medicare AdvantagePrior AuthMedium impact
Eprontia® (topiramate) oral solution (New)
Humana·Neurology, Family Medicine, Internal Medicine +1 more·Medicare Advantage
Effective date
Jan 1, 2026
We identified it
Jun 24, 2026
Summary
Humana Medicare Advantage now requires prior authorization for Eprontia (topiramate) oral solution effective January 1, 2026. This affects patients with epilepsy (age 2+) and migraine prevention (age 12+), with specific criteria including previous trial or intolerance to immediate-release topiramate tablets/capsules.
Action Required
Before January 1, 2026: Billing team must update prior authorization requirements for Eprontia (topiramate) oral solution prescriptions for Humana Medicare Advantage patients. Providers must document patient age requirements (2+ for epilepsy, 12+ for migraine), previous treatment history with immediate-release topiramate, and additional step therapy requirements for migraine patients. Claims without prior authorization will be denied.